Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Early Adoption of Tenofovir Alafenamide (TAF) for Hepatitis B in US Clinical Practice; Real-World Evidence from the Trio Network Curry, M. P., Bae, H., Dieterich, D. T., Ankoma-Sey, V., Reddy, K., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Reau, N., Frazier, L., Milligan, S., Afdhal, N. H. WILEY. 2018: 252A
View details for Web of Science ID 000446020500426